On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII-Reference-Cited by-同舟云学术

On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII

Published:2011-07-19 Issue:2 Volume:18 Page:255-262
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

SØRENSEN B.,DARGAUD Y.,KENET G.,LUSHER J.,MUMFORD A.,PIPE S.,TIEDE A.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2011.02612.x/fullpdf

Reference39 articles.

1. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference;Berntorp;Haemophilia,2006

2. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors;Gringeri;Haemophilia,2005

3. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors’ Organization (UKHCDO);Hay;Br J Haematol,2000

4. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation;Hay;Br J Haematol,2006

5. Current opinion on inhibitor treatment options;Mathew;Semin Hematol,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of recombinant factor VIIa in the clinical management of severe postpartum hemorrhage: consensus among European experts;The Journal of Maternal-Fetal & Neonatal Medicine;2024-01-02

2. Intracranial Hemorrhages in Neonates: Incidence, Risk Factors, and Treatment;Seminars in Thrombosis and Hemostasis;2022-09-15

3. Barriers and challenges for the fast treatment of bleeds in the non‐haemophilia treatment centre hospital setting;Haemophilia;2020-03-09

4. The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors;Haemophilia;2019-09-05

5. The future of bypassing agents for hemophilia with inhibitors in the era of novel agents;Journal of Thrombosis and Haemostasis;2018-10-11